Impact Factor
3.22
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.85
2,442 total citations
h5-index
47
h5 depth signal
Cited share
37.8%
519 of 1,374
Total citations
2,442
Citation footprint
Metric signal
1.55
External metric anchor
Self-citation
2.2%
53 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,139
Italy
553
China
386
Germany
343
United Kingdom
338
Citing Fields of Research
Neurodegenerative Disorders
4,704
Neurosciences
971
Postural Control
673
Migraines & Headaches
576
Nervous System Disorders
485
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
12,670
Articles tracked across the journal lifetime
Indexed publication set
1,374
519 cited publications
Last 12 months
399
33.3 publications/month
Open access share
26.8%
107 OA publications in the last year
Leading citing country
United States
1,139 citing publications
Leading citing field
Neurodegenerative Disorders
4,704 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v8n1, Sept. 2001-
v8n1, Sept. 2001-
Active Coverage
Research Focus & Classification
Indexed Subjects
Neurodegenerative Disorders
Broad Categories
Neurology
Neurodegenerative Disorders
MeSH Descriptors
Movement Disorders
Nerve Degeneration
Nervous System Diseases
Parkinson Disease
Tremor
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.parkreldis.2026.109022
Open DOI
DAT-SPECT findings in POLR3A-related striatal variant: a case report and literature review
02
03
DOI 10.1016/j.parkreldis.2026.109004
Open DOI
Distinct Handwriting Kinematic Profiles Across Parkinson’s Disease Subtypes
04
DOI 10.1016/j.parkreldis.2026.109021
Open DOI
Hierarchical deep learning–radiomics fusion for differentiating Parkinson's disease from atypical Parkinsonism using FP-CIT imaging
05
DOI 10.1016/j.parkreldis.2026.109020
Open DOI
Elevated erythrocyte membrane pS42-α-synuclein in Parkinson's disease and its changes following plasma cross-incubation
06
DOI 10.1016/j.parkreldis.2026.109016
Open DOI
Sensor-derived turning measures for differentiating earlier-stage Parkinson's disease and characterizing motor severity
07
DOI 10.1016/j.parkreldis.2026.109017
Open DOI
Evaluating multivariable clinical prediction models for Parkinson's disease prognosis: A scoping review
08
DOI 10.1016/j.parkreldis.2026.109018
Open DOI
Modeling disease progression among moderate-stage Parkinson's disease patients: A targeted literature review
09
DOI 10.1016/s1353-8020(26)00806-0
Open DOI
Editorial Board
10
DOI 10.1016/j.parkreldis.2026.108996
Open DOI
The ever-expanding universe of botulinum neurotoxin in movement disorders
Bibliographical & Catalog Notes
Also available online.
v. 4, no. 3 (Oct. 1998)20020918 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper